NEW YORK – Spectrum Solutions on Wednesday announced a sponsored research study with the University of California, Los Angeles to explore the use of saliva for early-stage lung cancer detection. The group aims to validate saliva tumor-specific circulating tumor DNA (ctDNA) detection sensitivity and positive agreement against tissue biopsy-based genotyping.